10th KUMAMOTO AIDS Seminar -GCOE Joint International Symposium
Poster Session　　　 ■　28 September　( 5th floor, Hall “Amakusa”　14:40 - 16:10 )
	P-01	Jagdagsuren Davaalkham [IMCJ & Kumamoto Univ.]	Current Hot Spot of HIV-1 Transmission in Mongolia
	P-02	Youichi Ogawa [Univ. of Yamanashi]	Production of LL-37 during herpes simplex virus types 2 infection in human keratinocytes enhances HIV susceptibility in Langerhans cells
	P-03	Tamayo Watanabe [IMCJ & Kumamoto Univ.]	Trends of AIDS indicative diseases, malignancies, and cause of death in HIV-infected patients in Japan
	P-04	Tsunefusa Hayashida [IMCJ & Kumamoto Univ.]	Latest trends in HIV infection derived from a BED assay.
	P-05	Kiyoto Tsuchiya [IMCJ]	Comparison of real-time PCR methods for measurement of plasma HIV-1 RNA
	P-06	Yoshioki Shiraishi [Kumamoto Univ.]	Radiotherapy inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis.
	P-07	Tomomi Towata [Kumamoto Univ.]	Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo
	P-08	Yoshinori Sato [Kumamoto Univ.]	Impaired differentiation and function of human CD8+ T cells in humanized mice
	P-09	Takashi Chihara [Kumamoto Univ.]	Functional analysis of human IL-34 that shares the receptor Fms with M-CSF: toward the establishment of humanized mice with human monocyte/macrophages
	P-10	Hiromi Ogata-Aoki [Kumamoto Univ.]	Study of the early phase dynamics of HIV-1 infection in huPBM-transplanted NOD/Scid/Jack3-/- mice using newly generated infectious mCherry-carrying HIV-1: Part 1
	P-11	Nobuyo Higashi-Kuwata [Kumamoto Univ.]	Study of the early phase dynamics of HIV-1 infection in huPBM-transplanted NOD/Scid/Jack3-/- mice using newly generated infectious mCherry-carrying HIV-1: Part 2
	P-12	Shinichiro Hattori [Kumamoto Univ.]	Potent activity of a NRTI, 4’-ethynyl-2-fluoro-2’deoxyadenosine, against HIV-1 infection in a model using human PBMC-transplanted NOJ mice
	P-13	Junko Shibata [Tokyo Medical and Dental Univ.]	Within-host HIV-1 Coevolution between Protease Inhibitor-Resistant Mutation D30N/N88D and Gag cleavage-Site Mutation P453L
	P-14	Kazuhiko Ide [Kumamoto Univ.]	Novel HIV-1 protease inhibitors (PIs) containing bis-tetrahydrofuran (bis-THF) and novel polycyclic ligand with protease (PR) dimerization inhibition activity.
	P-15	Masayuki Amano [Kumamoto Univ.]	Enhanced degradation of Gag proteins in multi-drug-resistant HIV variants containing insertions in Gag proteins
	P-16	Yasushi Tojo [Kumamoto Univ.]	Macrocyclic component-containing protease inhibitors (PIs) active against multi-PI-resistant HIV-1 in vitro
	P-17	Yuan Yuzhe [Kumamoto Univ.]	Effect of N terminus of HIV-1 protease on development of protease inhibitor resistance
	P-18	Manabu Aoki [Kumamoto Univ.]	The binary mechanism of HIV-1 resistance to tipranavir (TPV): Loss of inhibition of protease catalytic activity and protease dimerization
	P-19	Kensaku Anraku [Kumamoto Health Science Univ.]	Highly sensitive analysis for interaction between human immunodeficiency virus type 1 Gag and phosphoinositide derivatives based on surface plasmon resonance
	P-20	Koji Watanabe [IMCJ & Kumamoto Univ.]	Emergence of Raltegravir-Resistant HIV-1 in the Central Nervous System
	P-21	Shigeyoshi Harada [Kumamoto Univ.]	Generation of an integrase inhibitor raltegravir resistant variants using recent primary isolates, X4, R5 and dual/mix HIV-1.
	P-22	Chihiro Ochiai [Tokyo Medical and Dental Univ.]	Development of CD4 mimic small molecules targeted for dynamic supramolecular mechanism of HIV entry
	P-23	Kazuhisa Yoshimura [Kumamoto Univ.]	In vitro induction and characterization of subtype BC primary HIV-1 resistant to the CCR5 antagonist maraviroc.
	P-24	Tetsuya Ishikawa [Kumamoto Univ.]	Mutations in gp120 of R5 HIV-1 laboratory isolate induced by the in vitro selection of maraviroc confer highly sensitive to anti-V3 monoclonal antibodies
	P-25	Makiko Hatada [Kumamoto Univ.]	Mechanism of maintaining a glycan-insertion in HIV-1 gp120 V2 region under pressure of a potent neutralizing antibody in vitro
	P-26	Keisuke Yusa [Kumamoto Univ.]	Variable replication fitness dependent on CCR5 expression level in HIV-1 carrying V3 loop mutations
	P-27	Teppei Toda [Kumamoto Univ.]	Development of new high-affinity monoclonal antibodies against human CD4 that effectively inhibit HIV infection
	P-28	Takeo Kuwata [Kumamoto Univ.]	Naive cell depletion of both CD4+ and CD8+ T cells in SIV infection are associated with induction of autoeactive antibodies
	P-29	Nan Zheng [Kumamoto Univ.]	Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress HIV-1 replication in HIV-1-infected CD4+ T cells and macrophages
	P-30	Keiko Sakai [Kumamoto Univ.]	An effect of nadir CD4 counts on the persisting imbalance of CD4+ T-cell subsets in patients chronically infected with HIV-1
	P-31	Madoka Koyanagi [Kumamoto Univ.]	HIV-1 specific cytotoxic CD4+ T cell response against HIV-1 Nef, Gag and Pol
	P-32	Hayato Murakoshi [Kumamoto Univ.]	Control of HIV-1 by HIV-1 Pol-specific CD8+ T cells in chronically HIV-1-infected Japanese cohort
	P-33	Hiroshi Takata [Kumamoto Univ.]	Functional and gene expression analysis in human effector CD8+ T cells
	P-34	Kazutaka Honda [Kumamoto Univ.]	Selection of escape mutant by HLA-C-restricted HIV-1-specific cytotoxic T lymphocytes having a strong ability of to suppress HIV-1 replication
	P-35	Nozomi Kuse [Kumamoto Univ.]	Competitive HIV-1 replication suppression assay: selection of HIV-1 escape mutants by HLA-B*5101-restricted Pol283-8-specific CTLs.
	P-36	Masao Hashimoto [Kumamoto Univ.]	Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals
	P-37	Chihiro Motozono [Kumamoto Univ.]	The epitopes dictate the cross reactive capacity of HIV-specific CTLs towards variant antigens
	P-38	Philip Mwimanzi [Kumamoto Univ.]	The effects of CTL-escape conferring mutations on Nef's pathogenic functions in primary macrophages.
	P-39	Ranya Hassan [Kumamoto Univ.]	Dys-regulated activation of a tyroine kinase Hck at the Golgi by Nef disturbs the process of N-glycosylation
	P-40	Masateru Hiyoshi [Kumamoto Univ.]	Functional evaluation of a small-molecule compound 2c that targets HIV-1 Nef
	P-41	Taisuke Izumi [Kyoto Univ.]	A novel HIV-1 Vif function is mediated by interaction with oncoprotein p53
	P-42	Takayoshi Koyama [IMCJ]	HIV-1-induced DNA double-strand breaks enhance the infectivity into resting macrophage
	P-43	Yukihito Ishizaka [IMCJ]	Detection of Vpr in plasma of HIV-1 positive patients and Vpr-induced genomic instability: implication for HIV-1-associated malignancy
	P-44	Hirotaka Takahashi [Ehime Univ.]	In vitro high-throughput screening of host protein kinases binding to HIV-1 accessory proteins, Vif, Vpu and Vpr, based on wheat cell-free system
	P-45	Shoukichi Takahama [Ehime Univ.]	Atypical protein kinase C positively regulates the Vpr incorporation into HIV-1 particles by phosphorylating Gag p6
	P-46	Tadashi Watanabe [Kyoto Univ.]	Rho GTPase Rac2 modulates HIV-1 replication
	P-47	Ken Kono [Osaka Univ.]	The Old World monkey TRIM5a restriction of human immunodeficiency virus type 2
	P-48	Terumasa Ikeda [Kumamoto Univ.]	Intrinsic restriction activity by APOBEC1 against the mobility of autonomous retrotransposons
	P-49	Khaled Hussein Abd El Galil [Kumamoto Univ.]	ApoB mRNA editing enzyme APOBEC1-dependent restriction of HIV-1 in rabbit cells
	P-50	Kazuhiko Maeda [Kumamoto Univ.]	GANP participates in the host complex associated with HIV infection
	P-51	Yosuke Maeda [Kumamoto Univ.]	The inefficient HIV-1 entry/fusion in HUT78 cell line independent of the entry pathway
	←28 September		←29 September
Back